Research

Over One-Third of Under 50s Open to Psychedelic Trials for Mental Health Treatment
Aside from psilocybin, those aged between 18-24 were most interested psychedelic trials with ketamine (27%) and MDMA (26%)....
Researchers at Imperial’s Centre for Psychedelic Research will investigate psilocybin-assisted therapy for gambling addiction, aiming to improve their understanding of...
Insights from a Canadian survey reveal that while more than a third use natural psychedelics to self-medicate a health condition,...
In a recent study, researchers delved into the neurological effects of three widely debated practices: taking psychedelics, meditation, and hypnosis....
A new study has sought to find the effect near-death experiences and psychedelic trips have on our thoughts of death,...
Massachusetts is pushing for legalization on the 2024 ballot, a move that could change the game. A recent study has...
A new study published in Science Direct reveals that psychedelics activate parts of the Default Mode Network, contrary to previous...
Michael Pollan provides insights into the current psychedelic landscape. Minneapolis mayor unilaterally deprioritizes entheogen-related arrests. Synthetic psilocybin-assisted therapy shows promise...
Unraveling the significance of DMT Jesters through a Jungian lens, delving into their role as trickster archetypes....